Search research articles
Contact Us
Filters
Showing results (31-40 of 94) with videos related to
Page
of 10
Sort By:
Immunologic Research
|
December 15, 2015
Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity
Ricardo García-Muñoz, Ascensión López-Díaz-de-Cerio, Jesus Feliu, et al.
Medicina Clinica
|
January 20, 2012
[Guidelines for diagnosis, treatment and monitoring of primary immune thrombocytopenia]
Miguel Ángel Sanz, Vicente Vicente García, Antonio Fernández, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 25, 2016
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Monica Cabrero, Alejandro Martin, Javier Briones, et al.
Cancer
|
May 5, 2016
Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies
Hagop M Kantarjian, Anthony S Stein, Ralf C Bargou, et al.
Journal of Clinical Microbiology
|
December 26, 2008
Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive Aspergillosis in patients with febrile neutropenia
Manuel Cuenca-Estrella, Yolanda Meije, Carmen Diaz-Pedroche, et al.
Cancer
|
June 12, 2009
Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas
Cristina Robledo, Juan L García, Dolores Caballero, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular
|
January 24, 2021
The <sup>18</sup>F phantom clinical trials qualification for <sup>18</sup>F-FDG-PET scanning adopted by GELTAMO (Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea)
Fabrizio Bergesio, Adriano De Maggi, Mónica Coronado, et al.
Leukemia & Lymphoma
|
April 18, 2009
Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma
Ana I Saez, Mónica García-Cosío, Antonio J Sáez, et al.
European Journal of Haematology
|
December 20, 2007
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group
Reyes Arranz, Eulogio Conde, Carlos Grande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2008
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96
Josep-María Ribera, Albert Oriol, Miguel-Angel Sanz, et al.
Page
of 10
Search research articles
Search
Showing results (31-40 of 94) with videos related to
Sort By:
Page
of 10
Immunologic Research
|
December 15, 2015
Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity
Ricardo García-Muñoz, Ascensión López-Díaz-de-Cerio, Jesus Feliu, et al.
Medicina Clinica
|
January 20, 2012
[Guidelines for diagnosis, treatment and monitoring of primary immune thrombocytopenia]
Miguel Ángel Sanz, Vicente Vicente García, Antonio Fernández, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 25, 2016
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Monica Cabrero, Alejandro Martin, Javier Briones, et al.
Cancer
|
May 5, 2016
Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies
Hagop M Kantarjian, Anthony S Stein, Ralf C Bargou, et al.
Journal of Clinical Microbiology
|
December 26, 2008
Value of serial quantification of fungal DNA by a real-time PCR-based technique for early diagnosis of invasive Aspergillosis in patients with febrile neutropenia
Manuel Cuenca-Estrella, Yolanda Meije, Carmen Diaz-Pedroche, et al.
Cancer
|
June 12, 2009
Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas
Cristina Robledo, Juan L García, Dolores Caballero, et al.
Revista Espanola De Medicina Nuclear E Imagen Molecular
|
January 24, 2021
The <sup>18</sup>F phantom clinical trials qualification for <sup>18</sup>F-FDG-PET scanning adopted by GELTAMO (Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea)
Fabrizio Bergesio, Adriano De Maggi, Mónica Coronado, et al.
Leukemia & Lymphoma
|
April 18, 2009
Identification of biological markers of sensitivity to high-clinical-risk-adapted therapy for patients with diffuse large B-cell lymphoma
Ana I Saez, Mónica García-Cosío, Antonio J Sáez, et al.
European Journal of Haematology
|
December 20, 2007
Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group
Reyes Arranz, Eulogio Conde, Carlos Grande, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2008
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96
Josep-María Ribera, Albert Oriol, Miguel-Angel Sanz, et al.
Page
of 10